Get started
Work

Recurrent Cardiac Tamponade from Multiple Myeloma While Receiving Teclistamab

Year: 2024
Type: article
Study design: Case Report
Abstract: Bispecific therapy has changed the treatment paradigm for multiple myeloma. We report a patient with recurrent malignant pericardial effusions with cardiac tamponade and new atrial fibrillation during treatment, suggesting that new or worsening pericardial disease may be a potential cardiovascular adverse effect of bispecific therapy.
DOI: 10.1016/j.jaccas.2024.102763
Authors: Alexander Hurtado, Samuel T. Luebbe, Emma Kilbane, Toluwalase Awoyemi, Taylor Bronson, Jayesh Mehta, Mohamed M.H. Al-Kazaz, Adam Y. Lin
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $850
OpenAlex ID: W4405014631
FWCI: 0.534
Cites: 7
Cited by: 2
Related to: 10